Equitech-Bio Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Equitech-Bio's estimated annual revenue is currently $3.7M per year.(i)
  • Equitech-Bio's estimated revenue per employee is $155,000

Employee Data

  • Equitech-Bio has 24 Employees.(i)
  • Equitech-Bio grew their employee count by 0% last year.

Equitech-Bio's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M11-8%N/AN/A
#2
$14.9M96-6%N/AN/A
#3
$15.2M983%$1.8MN/A
#4
$1.6M100%N/AN/A
#5
$3.4M220%N/AN/A
#6
$2.8M1850%N/AN/A
#7
$7.4M48-2%N/AN/A
#8
$0.8M50%N/AN/A
#9
$1.6M100%N/AN/A
#10
$16.3M10562%N/AN/A
Add Company

What Is Equitech-Bio?

For over 25 years Equitech-Bio, Inc. has been a dynamic leader and preferred OEM supplier of biologicals for biopharmaceutical research labs, diagnostic and academic institutions worldwide. We are a mission-driven company that aims to set the standards of excellence for the biotech industry. We are a business in which high standards permeate all aspects of our company. Equitech-Bio is continually researching and implementing new filtration technologies and products to ensure we are meeting and exceeding industry standards, trends and client demands. Whether it is a custom antibody order or a bulk filtration, we are committed to producing high quality product with rapid turnaround.We invite those new to Equitech-Bio to join thousands of satisfied clients who use us as their primary supplier for animal and human biologicals by giving our friendly Customer Success Team a call at 1-800-259-0591 or sending us an email to sales@equitech-bio.com or visit us at www.equitech-bio.com. Be sure and stay tuned for news on some exciting product developments in the near future! We look forward to hearing from you.

keywords:N/A

N/A

Total Funding

24

Number of Employees

$3.7M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6M3011%N/A
#2
$7.2M31-9%N/A
#3
$4M3111%N/A
#4
$9.2M359%N/A
#5
N/A356%N/A